Atmiyata, a community champion led psychosocial intervention for common mental disorders: A stepped wedge cluster randomized controlled trial in rural Gujarat, India

• Published in: PloS one Vol. 18; no. 6; p. e0285385
• Main Authors: Pathare, Soumitra, Joag, Kaustubh, Kalha, Jasmine, Pandit, Deepa, Krishnamoorthy, Sadhvi, Chauhan, Ajay, Shields-Zeeman, Laura
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 08.06.2023; Public Library of Science (PLoS)
• Subjects: Analysis; Anxiety; Anxiety - therapy; Anxiety disorders; Anxiety Disorders - therapy; Care and treatment; Clinical trials; Clusters; Community; Consent; Counseling; Data collection; Depression, Mental; Diagnosis; Earth Sciences; Effectiveness; Humans; India; Intervention; Medical personnel; Medicine and Health Sciences; Mental depression; Mental disorders; Mental Disorders - psychology; Mental health; Mental health care; Psychiatric services; Psychological aspects; Psychosocial Intervention; Quality of Life; Questionnaires; Self destructive behavior; Signs and symptoms; Social Sciences; Suicides & suicide attempts; Towns; India; Gujarat India
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0285385

While effective lay-health worker models for mental health care have been demonstrated through efficacy trials, there is limited evidence of the effectiveness of these models implemented in rural LMIC settings. To evaluate the impact of a volunteer community-led intervention on reduction in depression and anxiety symptoms and improvement in functioning, and social participation among people living in rural Gujarat, India. Stepped-wedge cluster randomized controlled trial was used to assess the effectiveness of delivery of psychosocial intervention across 645 villages in Mehsana district of Gujarat, India between April 2017 and August 2019. The primary outcome was an improvement in depression and/or anxiety symptoms assessed using GHQ-12 at 3-month follow-up. Secondary outcomes were improvement in (a) depression and anxiety (Patient Health Questionnaire, (PHQ-9), Generalized Anxiety Disorder (GAD-7) & Self-Reporting Questionnaire-20 (SRQ-20); b) quality of life (EQ- 5D); c) functioning (WHO-DAS-12), and social participation (Social Participation Scale SPS). Generalized linear mixed-effects models were used to assess the independent effect of the intervention. Out of a total of 1191 trial participants (608- intervention & 583-control), 1014 (85%) completed 3-month follow-up. In an adjusted analysis, participants in the intervention condition showed significant recovery from symptoms of depression or anxiety (OR 2.2; 95% CI 1.2 to 4.6; p<0.05) at the end of 3-months, with effects sustained at 8-month follow-up (OR 3.0; 95% CI 1.6 to 5.9). Intervention participants had improved scores on the PHQ-9 (Adjusted mean difference (AMD) -1.8; 95%CI -3.0 to -0.6), and SRQ-20 (AMD -1.7; 95%CI -2.7 to -0.6), at 3-months and PHQ-9, GAD-7, SRQ-20, EQ-5D and WHO-DAS at 8 months follow-up. Findings suggest that Atmiyata had a significant effect on recovery from symptoms of depression and anxiety with sustained effects at 8-month follow-up. Trial registration details. The trial was registered prospectively with the "Clinical Trial Registry in India" (registry number: CTRI/2017/03/008139).